The CEO of CVS Health has stepped down as the company shares continue to struggle, falling 19% this year.
Karen Lynch, will be replaced by CVS Health executive David Joyner, according to The Associated Press.
Leerink Partners analyst Michael Cherny said that he didn’t expect a change in leadership, but that it made sense in light of the company’s performance.
“It is hard, given the operational and stock underperformance, to say a change at the top is undeserved,” he said in a research note.Earlier this month it was reported that CVS would lay off about 2,900 employees as part of an effort to reduce costs by $2 billion.The Wall Street Journal reported that CVS is going to conduct a strategic review and potentially break up the healthcare company, citing anonymous sources.
— Read More: justthenews.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
